Faculty Directory
Harvard T.H. Chan School of Public Health Executive and Continuing Education programs are taught by esteemed Harvard faculty and industry experts in health care and related fields.
Harvard Chan Executive and Continuing Education Faculty
Richard Siegrist is senior lecturer on health care management at the Harvard T.H. Chan School of Public Health, where he teaches physician, graduate, and executive education courses on financial management, cost accounting, management control, innovation and entrepreneurship. He is also the faculty director of the DrPH program, director of the master in health care management program for physicians, and the director of innovation and entrepreneurship for Harvard Chan. He received the Roger L. Nichols Excellence in Teaching Award for 2008. In addition, he teaches in the Chairs of Clinical Services and the Leadership Strategies for Evolving Healthcare Executives programs.Richard was previously CEO…
Dr. Siepmann is an attending physician, head of the Neurovascular Outpatient Clinic and stroke researcher at University Hospital Carl Gustav Carus in Dresden, Germany who dedicated his career to elucidating pathophysiological mechanisms and identifying diagnostic and therapeutic targets in neurovascular and autonomic disorders. His clinical and scientific focus is on stroke care, neuropharmacology, autonomic nervous system pathways including the brain-and-heart axis and the association of COVID-19 and ischaemic stroke. After graduating from Charité Medical School in Berlin in 2008 and after receiving his doctoral degree from the University of Technology Dresden in 2009, he received postdoctoral training at the University…
Dr. Kevin Simon, a practicing pediatric addiction medicine psychiatrist, is Boston’s first Chief Behavioral Health Officer appointed by Mayor Michelle Wu. As Chief Behavioral Health Officer, Simon leads a Citywide behavioral health strategy and plan through the Boston Public Health Commission. Simon is the rare academic triple threat, a physician who conducts original research, inspires learners and provides exemplary clinical care. He is also a health policy expert and a noted writer. He is an attending physician in the Boston Children’s Hospital Adolescent Substance Use and Addiction Program (ASAP), an instructor of psychiatry at Harvard Medical School, a Commonwealth fund fellow…
Christopher Simon is President and President and Chief Executive Officer of Haemonetics, a provider of medical technology solutions designed to improve the quality, effectiveness and efficiency of care. Mr. Simon has more than 30 years of experience helping businesses transform and grow. He was a Senior Partner at McKinsey & Company and led its Global Medical Products Practice. He also held commercial and operating roles at Baxter Healthcare Corporation. He is a former U.S. Army Infantry Officer and earned a Bachelor of Science in Economics from The Wharton School at the University of Pennsylvania and an MBA from Harvard Business School. Mr.…
Donald C. Simonson, M.D., M.P.H., Sc.D. is a member of the Division of Endocrinology, Diabetes and Hypertension at Brigham and Women’s Hospital and a Lecturer on Medicine at Harvard Medical School. He received his BA and MD degrees from Yale University, and completed his postdoctoral fellowship in Endocrinology and Metabolism at Yale in 1983. After 4 years on the faculty at Yale, he became Head of the Section on Clinical Physiology at Joslin Diabetes Center in 1987, and Chief of Diabetes and Metabolism at Brigham and Women’s Hospital in 1992, both in Boston. While on a mid-career sabbatical, he received…
Dr. Dilpreet Singh is a Senior Scientist in the Health Sciences practice at Exponent, where he provides consulting services in the area of quantitative exposure assessment and risk modeling of consumer products and occupational environments involving use of emerging chemicals and advanced materials including nanoparticles. Dr. Singh specializes in the design and development of lab-based platforms and approaches for assessing lifecycle-specific exposures to engineered nanomaterials and incidental nanoparticles in occupational, consumer product use and environmental settings. During his doctoral and postdoctoral research at the Harvard T.H. Chan School of Public Health, Dr. Singh performed extensive physicochemical, morphological, and toxicological characterization of…
John Skiffington is the Director of AI Engineering at the Mayo Clinic Center for Digital Health, where he oversees teams of MLOps Engineers who deploy ML models into clinical practice.
Tom Smith is the President and CEO of 3Flow. Mr. Smith has worked for more than 30 years helping facilities provide safe, efficient, and sustainable performance of labs and critical workspaces. He holds a Bachelor of Science in Mechanical Engineering from North Carolina State University and a Master of Science in Industrial Hygiene from the University of North Carolina. Mr. Smith has chaired and served on numerous committees for the development of national and international standards on Ventilation for safety and Health. He serves on the Board for the International Institute of Sustainable Labs (I2SL) and is a member of…
Arthur Soma has been in the nuclear filtration industry for more than 20 years. He currently participates on several nuclear air cleaning code writing committees for the American Society of Mechanical Engineers and is the chair for Working Group 8 (High Efficiency Gas Phase Adsorbers) for the Institute of Environmental Sciences and Technology. Art currently holds the position of Product Manager – Nuclear and Containment with Camfil and is responsible for managing Camfil’s containment product mix. He attended Franklin University (Columbus, Ohio) and currently lives in Columbus, Ohio.
Mike Spadafore is a Managing Director of the Blue Venture Fund and Sandbox Industries. The Blue Venture Fund program is a unique partnership between over 30 BCBS entities, BCBSA, and Sandbox Industries and represents over $850M assets under management. As part of his role with the Fund, Mike helps lead the investment team, set investment strategy, manage the portfolio, and engage with Blue Plan executives across the system. Mike serves as a Board Member of ID Experts, Prove, Physera, Wellframe, WiderCircle, Abacus Insights and Workit Health. He is also a Board Observer for Octave Biosciences and Emids. Prior to joining Sandbox,…